Study to Evaluate the Effect of Secukinumab Compared to Placebo on Aortic Vascular Inflammation in Subjects With Moderate to Severe Plaque Psoriasis
Clinical trial NCT02690701 · COMPLETED
Trial details
- NCT number
- NCT02690701
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-10
- Primary completion
- 2017-04-26
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.